Eve Burstein
Stock Analyst at Bernstein
(2.26)
# 2,558
Out of 4,778 analysts
22
Total ratings
38.46%
Success rate
2.98%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $135 → $145 | $120.38 | +20.45% | 3 | Jan 10, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $151.65 | +31.89% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $107.90 | +34.39% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $369.66 | -2.61% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $46.08 | +95.33% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $46.72 | -25.09% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $515.53 | +20.26% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.31 | +91.57% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $16.34 | +34.68% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $85.53 | +29.79% | 1 | Sep 28, 2023 |
Agilent Technologies
Jan 10, 2025
Maintains: Market Perform
Price Target: $135 → $145
Current: $120.38
Upside: +20.45%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $151.65
Upside: +31.89%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $107.90
Upside: +34.39%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $369.66
Upside: -2.61%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $46.08
Upside: +95.33%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $46.72
Upside: -25.09%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $515.53
Upside: +20.26%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.31
Upside: +91.57%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $16.34
Upside: +34.68%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $85.53
Upside: +29.79%